Latest Insider Transactions at Alignment Healthcare, Inc. (ALHC)
This section provides a real-time view of insider transactions for Alignment Healthcare, Inc. (ALHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Alignment Healthcare, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Alignment Healthcare, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 09
2023
|
Joseph S Konowiecki Director |
BUY
Open market or private purchase
|
Direct |
100,000
+8.94%
|
$600,000
$6.62 P/Share
|
|
Mar 08
2023
|
Thomas J. Carella Director |
BUY
Grant, award, or other acquisition
|
Direct |
29,070
+25.6%
|
-
|
|
Mar 08
2023
|
Jacqueline B Kosecoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
29,070
+10.86%
|
-
|
|
Mar 08
2023
|
Mark B. Mc Clellan Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,802
+6.47%
|
-
|
|
Mar 08
2023
|
Nicholas Robbert Vorhoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,337
+29.77%
|
-
|
|
Mar 08
2023
|
Jeffrey H Margolis Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,802
+22.65%
|
-
|
|
Mar 08
2023
|
Margaret M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,802
+20.78%
|
-
|
|
Mar 08
2023
|
Jody L Bilney Director |
BUY
Grant, award, or other acquisition
|
Direct |
29,070
+33.49%
|
-
|
|
Mar 08
2023
|
Yon Jorden Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,802
+30.16%
|
-
|
|
Mar 08
2023
|
David C Hodgson Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,337
+29.77%
|
-
|
|
Mar 02
2023
|
Dawn Christine Maroney President |
SELL
Bona fide gift
|
Direct |
6,800
-0.35%
|
-
|
|
Feb 01
2023
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-0.9%
|
$120,000
$12.19 P/Share
|
|
Jan 18
2023
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
1,100
-0.21%
|
$14,300
$13.01 P/Share
|
|
Jan 18
2023
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
1,100
-0.04%
|
$14,300
$13.01 P/Share
|
|
Jan 18
2023
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
1,125
-0.1%
|
$14,625
$13.01 P/Share
|
|
Jan 17
2023
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
5,000
-0.25%
|
$60,000
$12.54 P/Share
|
|
Jan 13
2023
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.8%
|
$108,000
$12.09 P/Share
|
|
Jan 03
2023
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
1,000
-0.09%
|
$12,000
$12.01 P/Share
|
|
Dec 21
2022
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
4,274
-0.22%
|
$51,288
$12.01 P/Share
|
|
Dec 15
2022
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
726
-0.04%
|
$8,712
$12.02 P/Share
|
|
Dec 01
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
25,000
-0.91%
|
$325,000
$13.11 P/Share
|
|
Dec 01
2022
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
24,000
-4.41%
|
$312,000
$13.1 P/Share
|
|
Dec 01
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
20,000
-1.74%
|
$260,000
$13.08 P/Share
|
|
Nov 10
2022
|
Dawn Christine Maroney President |
SELL
Bona fide gift
|
Direct |
5,000
-0.25%
|
-
|
|
Nov 07
2022
|
Joseph S Konowiecki Director |
BUY
Grant, award, or other acquisition
|
Direct |
53,906
+5.54%
|
-
|
|
Nov 07
2022
|
Margaret M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,429
+2.28%
|
-
|
|
Nov 01
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
30,000
-2.55%
|
$390,000
$13.39 P/Share
|
|
Nov 01
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
25,000
-0.9%
|
$325,000
$13.23 P/Share
|
|
Nov 01
2022
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
24,000
-4.22%
|
$312,000
$13.23 P/Share
|
|
Oct 26
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
25,000
-0.89%
|
$325,000
$13.07 P/Share
|
|
Oct 26
2022
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
24,000
-4.05%
|
$312,000
$13.08 P/Share
|
|
Oct 26
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-0.84%
|
$130,000
$13.02 P/Share
|
|
Oct 03
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
20,000
-1.66%
|
$240,000
$12.03 P/Share
|
|
Sep 20
2022
|
Warburg Pincus Partners Gp LLC Director |
SELL
Open market or private sale
|
Indirect |
2,044,006
-10.24%
|
$28,616,084
$14.61 P/Share
|
|
Sep 20
2022
|
Warburg Pincus LLC Director |
SELL
Open market or private sale
|
Indirect |
2,044,006
-10.24%
|
$28,616,084
$14.61 P/Share
|
|
Sep 20
2022
|
General Atlantic (Aln Hlth), L.P. Director |
SELL
Open market or private sale
|
Indirect |
6,955,994
-10.24%
|
$97,383,916
$14.61 P/Share
|
|
Sep 20
2022
|
General Atlantic LLC Director |
SELL
Open market or private sale
|
Indirect |
6,955,994
-10.24%
|
$97,383,916
$14.61 P/Share
|
|
Sep 12
2022
|
Richard A. Cross SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
102,759
+20.41%
|
-
|
|
Sep 12
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
280,360
+18.85%
|
-
|
|
Sep 12
2022
|
Dawn Christine Maroney President |
BUY
Grant, award, or other acquisition
|
Direct |
431,323
+17.88%
|
-
|
|
Sep 12
2022
|
Robert Thomas Freeman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
319,179
+30.38%
|
-
|
|
Sep 12
2022
|
John E Kao Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,639,027
+40.38%
|
-
|
|
Sep 09
2022
|
Dawn Christine Maroney President |
SELL
Bona fide gift
|
Direct |
450
-0.03%
|
-
|
|
Sep 09
2022
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
10,250
-0.66%
|
$164,000
$16.6 P/Share
|
|
Sep 08
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
50,000
-5.12%
|
$800,000
$16.05 P/Share
|
|
Sep 01
2022
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
20,000
-1.27%
|
$280,000
$14.56 P/Share
|
|
Sep 01
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
30,000
-2.98%
|
$420,000
$14.56 P/Share
|
|
Sep 01
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
50,000
-1.75%
|
$700,000
$14.56 P/Share
|
|
Sep 01
2022
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
24,000
-3.89%
|
$336,000
$14.56 P/Share
|
|
Aug 23
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
50,000
-4.73%
|
$800,000
$16.0 P/Share
|